Instituto de Investigación Biomédica de A Coruña (INIBIC)
Research center
Novartis (Sweden)
Täby, SueciaPublications in collaboration with researchers from Novartis (Sweden) (10)
2024
-
Capmatinib plus nazartinib in patients with EGFR-mutated non–small cell lung cancer
European Journal of Cancer, Vol. 208
2020
-
NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study
JACC: Heart Failure, Vol. 8, Núm. 10, pp. 822-833
2019
-
Effects of serelaxin in patients with acute heart failure
New England Journal of Medicine, Vol. 381, Núm. 8, pp. 716-726
-
Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study
European Journal of Heart Failure, Vol. 21, Núm. 8, pp. 998-1007
2017
-
Secukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double-Blind, Active Comparator– and Placebo-Controlled Study
Arthritis and Rheumatology, Vol. 69, Núm. 6, pp. 1144-1153
2010
-
Novel in vitro co-culture methodology to investigate heterotypic cell-cell interactions
European Cells and Materials, Vol. 19, pp. 166-179
2007
-
Pharmacokinetics and variability of mycophenolic acid from enteric-coated mycophenolate sodium compared with mycophenolate mofetil in de novo heart transplant recipients
Clinical Transplantation, Vol. 21, Núm. 1, pp. 18-23
2004
-
Failure to deplete anti-Galα1-3Gal antibodies after pig-to-baboon organ xenotransplantation by immunoaffinity columns containing multiple Galα1-3Gal oligosaccharides
Xenotransplantation, Vol. 11, Núm. 5, pp. 408-415
2001
-
Removal of bowel aerobic gram-negative bacteria is more effective than immunosuppression with cyclophosphamide and steroids to decrease natural α-Galactosyl IgG antibodies
Xenotransplantation, Vol. 8, Núm. 1, pp. 15-23